Chicago, USA | March 13, 2026

Global medical technology leader GE HealthCare has announced the appointment of Kevin A. Lobo to its Board of Directors, effective March 13, 2026. The move is aimed at strengthening the company’s strategic direction and accelerating growth across its medical technology portfolio.

Kevin A. Lobo currently serves as Chair and Chief Executive Officer of Stryker Corporation, where he has led significant global expansion, innovation, and operational excellence. With extensive leadership experience in the healthcare and medical technology sectors, his appointment is expected to bring valuable insights into scaling innovation, global market strategy, and healthcare delivery transformation.

At GE HealthCare, Lobo will contribute to advancing the company’s focus on precision care, digital health solutions, and next-generation medical technologies, supporting its long-term vision of improving patient outcomes and expanding access to quality healthcare globally.

Industry experts note that the inclusion of seasoned leaders from across the medtech ecosystem reflects a growing emphasis on cross-industry expertise and strategic governance as healthcare companies navigate rapid technological advancements and evolving global health demands.

The appointment comes at a time when GE HealthCare continues to invest in innovation across imaging, diagnostics, and AI-driven healthcare solutions, positioning itself for sustained growth in a highly competitive global market.

Kevin A. Lobo’s addition to the board is expected to further strengthen the company’s leadership framework, enhance decision-making capabilities, and support its mission to deliver innovative, accessible, and patient-centric healthcare technologies worldwide.